Xian International Financials

000516 Stock   5.69  0.03  0.53%   
Please harness analysis of Xian International fundamentals to determine if markets are correctly pricing the firm. We were able to analyze twenty-seven available indicators for Xian International, which can be compared to its rivals. The stock experiences a moderate upward volatility. Check odds of Xian International to be traded at 6.26 in 90 days. Key indicators impacting Xian International's financial strength include:
Operating Margin
(0.04)
Profit Margin
(0.07)
Return On Equity
(0.13)
  
Understanding current and past Xian International Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Xian International's financial statements are interrelated, with each one affecting the others. For example, an increase in Xian International's assets may result in an increase in income on the income statement.
Please note, the presentation of Xian International's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Xian International's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Xian International's management manipulating its earnings.

Xian International Stock Summary

Xian International competes with Camelot Electronics, Guolin Environmental, Wuxi Dk, Bengang Steel, and Beijing SPC. Xian International is entity of China. It is traded as Stock on SHE exchange.
Specialization
Consumer Discretionary, Consumer Discretionary Distribution & Retail
InstrumentChina Stock View All
ExchangeShenzhen Stock Exchange
ISINCNE000000016
Business AddressSecurity Building, Xian,
SectorBroadline Retail
IndustryConsumer Discretionary
BenchmarkDow Jones Industrial
Websitewww.000516.cn
Phone86 29 8833 2551
You should never invest in Xian International without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Xian Stock, because this is throwing your money away. Analyzing the key information contained in Xian International's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Xian International Key Financial Ratios

Xian International's financial ratios allow both analysts and investors to convert raw data from Xian International's financial statements into concise, actionable information that can be used to evaluate the performance of Xian International over time and compare it to other companies across industries.

Xian International Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets12.1B13.3B13.3B11.3B13.0B13.7B
Other Current Liab292.2K312.0K2.4B323.7K372.2K353.6K
Net Debt3.6B3.6B3.3B3.7B4.3B4.5B
Retained Earnings2.6B1.8B642.5M274.1M315.2M621.8M
Accounts Payable2.1B2.1B2.0B2.1B2.4B2.6B
Cash1.0B1.5B1.2B944.0M1.1B782.4M
Inventory57.4M84.1M69.2M78.3M90.1M49.3M
Other Current Assets14.5M24.0M20.9M41.1M47.3M28.8M
Total Liab7.1B8.0B9.0B7.5B8.6B9.1B
Total Current Assets2.3B2.3B3.7B1.9B2.2B1.2B
Short Term Debt715.6M645.8M994.0M1.3B1.5B1.6B
Intangible Assets689.6M690.5M775.8M747.0M859.1M902.0M
Net Receivables711.1M408.3M2.3B713.0M820.0M861.0M
Other Liab2.4M13.7M44.3M40.9M47.1M49.4M
Long Term Debt3.9B4.5B3.5B3.4B3.9B4.1B
Net Tangible Assets5.2B4.4B4.3B4.6B5.3B4.3B
Short Long Term Debt410.3M225.8M549.1M604.5M695.2M461.9M
Net Invested Capital9.3B10.0B8.3B7.9B9.1B8.6B
Net Working Capital(803.5M)(1.2B)(1.8B)(2.2B)(2.0B)(1.9B)

Xian International Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
202020212022202320242025 (projected)
Interest Expense154.0M190.8M190.5M219.0M251.9M264.5M
Total Revenue1.6B2.9B2.7B4.6B5.3B2.7B
Operating Income(592.4M)(659.6M)(875.1M)(300.9M)(270.8M)(257.2M)
Cost Of Revenue1.8B2.9B2.9B4.2B4.8B5.0B
Income Before Tax7.4M(919.6M)(1.1B)(467.3M)(420.5M)(399.5M)
Net Income45.4M(822.2M)(1.2B)(368.4M)(331.5M)(314.9M)
Income Tax Expense805.9M28.0M(27.5M)(74.4M)(85.6M)(81.3M)
Minority Interest32.5M23.0M18.7M103.6M119.1M125.1M
Gross Profit(148.0M)43.4M(178.0M)440.8M396.8M278.5M
Ebit(283.9M)(641.0M)(673.9M)(895.3M)(805.8M)(765.5M)
Research Development9.7M12.8M15.5M9.8M11.3M7.5M
Tax Provision(27.5M)(74.4M)55.0M4.7M4.2M4.0M
Net Interest Income(151.3M)(176.9M)(184.7M)(216.4M)(194.8M)(185.0M)
Interest Income5.9M20.8M11.5M9.5M8.6M16.8M
Ebitda(204.0M)537.4M(160.2M)(329.5M)(296.5M)(281.7M)

Xian International Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Xian International. It measures of how well Xian is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Xian International brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Xian had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Xian International has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
202020212022202320242025 (projected)
Capital Expenditures1.3B1.7B1.2B762.7M877.1M623.9M
Net Income51.4M(822.2M)(1.2B)(368.4M)(331.5M)(314.9M)
Change To Inventory(4.8M)(26.6M)10.6M(9.1M)(8.2M)(7.8M)
Dividends Paid196.4M232.3M245.4M(217.4M)(250.0M)(237.5M)
Investments203.6M417.7M(818.0M)(762.0M)(685.8M)(651.5M)
Change In Cash(126.1M)560.2M(335.8M)(239.8M)(215.8M)(205.0M)
Net Borrowings402M2.7B1.2B259.7M298.7M283.8M
Depreciation363.8M568.6M594.1M769.9M885.4M929.6M
Change To Netincome108.0M(609.3M)262.8M248.0M285.3M299.5M
End Period Cash Flow959.5M1.5B1.2B944.0M849.6M1.2B
Free Cash Flow(1.3B)(1.2B)(726.5M)324.7M373.4M392.0M
Other Non Cash Items160.9M199.5M207.2M234.1M269.2M148.5M

Xian Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Xian International's current stock value. Our valuation model uses many indicators to compare Xian International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xian International competition to find correlations between indicators driving Xian International's intrinsic value. More Info.
Xian International Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Xian International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Xian International's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Xian International Systematic Risk

Xian International's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Xian International volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Xian International correlated with the market. If Beta is less than 0 Xian International generally moves in the opposite direction as compared to the market. If Xian International Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Xian International is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Xian International is generally in the same direction as the market. If Beta > 1 Xian International moves generally in the same direction as, but more than the movement of the benchmark.

Xian International Medical Total Assets Over Time

Xian International Thematic Clasifications

Xian International Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas

Xian International March 28, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Xian International help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Xian International Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Xian International Medical based on widely used predictive technical indicators. In general, we focus on analyzing Xian Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Xian International's daily price indicators and compare them against related drivers.

Complementary Tools for Xian Stock analysis

When running Xian International's price analysis, check to measure Xian International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xian International is operating at the current time. Most of Xian International's value examination focuses on studying past and present price action to predict the probability of Xian International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xian International's price. Additionally, you may evaluate how the addition of Xian International to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamental Analysis
View fundamental data based on most recent published financial statements